Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomes 04/24/2024 INTERVENTIONAL unchanged 854.85 0 Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability 04/24/2024 INTERVENTIONAL unchanged 854.85 0 The Project of Gestational Hypertension and Preeclampsia Screening and Prevention Center 04/25/2024 OBSERVATIONAL unchanged 853.85 0 Utidelone (UTD1) Plus Capecitabine in Non-pCR TNBC After Neoadjuvant Therapy 04/26/2024 INTERVENTIONAL unchanged 852.85 0 Surgical TReatment of Women With Deep ENDometriosis 04/26/2024 OBSERVATIONAL unchanged 852.85 0 Fasting During Neoadjuvant Chemotherapy in Patient With Epithelial Ovarian Cancer 04/26/2024 INTERVENTIONAL unchanged 852.85 0 DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients 04/29/2024 OBSERVATIONAL unchanged 849.85 0 Acupuncture for Chronic Pelvic Pain 04/29/2024 INTERVENTIONAL unchanged 849.85 0 Laser Treatment for Lichen Sclerosus 04/29/2024 INTERVENTIONAL unchanged 849.85 0 Synbiotic to Attenuate Resorption of the Skeleton 04/29/2024 INTERVENTIONAL unchanged 849.85 0 GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Atypical Hyperplasia Patients 04/30/2024 INTERVENTIONAL unchanged 848.85 0 Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer 04/30/2024 INTERVENTIONAL unchanged 848.85 0 Effect of Local Estriol Treatment Before Vaginal Repair Surgery 04/30/2024 INTERVENTIONAL unchanged 848.85 0 Evaluation of Salivary RNA in Subjects Scheduled for Surgery for a Gynecologic Pathology 05/01/2024 OBSERVATIONAL unchanged 847.85 0 Database Study to Provide Information on Pregnancy and Infant Outcomes Among Women Exposed to QUVIVIQ (Daridorexant) 05/01/2024 OBSERVATIONAL unchanged 847.85 0 Epsom Salt Compresses to Relieve Perineal for Postpartum Care: a Clinical Trial 05/01/2024 INTERVENTIONAL unchanged 847.85 0 SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer 05/01/2024 INTERVENTIONAL unchanged 847.85 0 A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer 05/01/2024 INTERVENTIONAL unchanged 847.85 0 Efficacy, Safety, and Acceptability of Mifepristone 50 mg Once-weekly as a Contraceptive 05/01/2024 INTERVENTIONAL unchanged 847.85 0 Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination 05/02/2024 INTERVENTIONAL unchanged 846.85 0 THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation 05/02/2024 INTERVENTIONAL unchanged 846.85 0 Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer 05/02/2024 INTERVENTIONAL unchanged 846.85 0 Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT) 05/02/2024 INTERVENTIONAL unchanged 846.85 0 DeVEnIR: Defining Vulvovaginal Candidiasis - Elements of Infection and Remedy 05/02/2024 OBSERVATIONAL unchanged 846.85 0 Navigating Pregnancy and Parenthood With Lyme Disease 05/03/2024 OBSERVATIONAL unchanged 845.85 0 Prospective on Market Patient-reported Outcomes for Milli 05/03/2024 OBSERVATIONAL unchanged 845.85 0 Stress Management Intervention Among Breast and Gynecologic Cancer Patients in Viet Nam 05/03/2024 INTERVENTIONAL unchanged 845.85 0 Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy 05/03/2024 OBSERVATIONAL unchanged 845.85 0 The Effect of Cognitive Exercise Therapy Approach and Yoga in Adolescents With Dysmenorrhoea 05/03/2024 INTERVENTIONAL unchanged 845.85 0 MRg-NIRS Imaging System Breast Cancer Trial 05/06/2024 INTERVENTIONAL unchanged 842.85 0 Comparison of the Efficacy of Cryotherapy Combined With Compression in Preventing Neuropathy 05/06/2024 INTERVENTIONAL unchanged 842.85 0 SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC) 05/06/2024 INTERVENTIONAL unchanged 842.85 0 Comparison of Music and Ambient Noise Cancellation in Patients Undergoing Total Knee Arthroplasty (TKA) 05/06/2024 INTERVENTIONAL unchanged 842.85 0 Pain and Physical Fitness in Primary Dysmenorrhea 05/06/2024 OBSERVATIONAL unchanged 842.85 0 Oncologic, Cosmetic and Patient Reported Outcomes in Value-Based Breast Surgery (OnCoPRO Value) 05/06/2024 OBSERVATIONAL unchanged 842.85 0 Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy 05/07/2024 OBSERVATIONAL unchanged 841.85 0 Gestrinone and Endothelial Function in Young Women 05/07/2024 OBSERVATIONAL unchanged 841.85 0 Supporting the National Expansion of HPV-based Cervical Cancer Screening in Tanzania Among Women Living With HIV 05/07/2024 INTERVENTIONAL unchanged 841.85 0 SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer 05/07/2024 INTERVENTIONAL unchanged 841.85 0 Evaluation of the PreCursor-M+® in CIN2 05/08/2024 OBSERVATIONAL unchanged 840.85 0 Timing of Surgery After Neoadjuvant Chemotherapy for Advanced Ovarian Cancer 05/08/2024 INTERVENTIONAL unchanged 840.85 0 Boost Irradiation to the Supraclavicular Area Among High Risk cN3c Breast Cancer Patients 05/08/2024 INTERVENTIONAL unchanged 840.85 0 Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment 05/08/2024 INTERVENTIONAL unchanged 840.85 0 Opioid-free Anaesthesia in Breast Cancer Surgery 05/08/2024 INTERVENTIONAL unchanged 840.85 0 Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer 05/09/2024 INTERVENTIONAL unchanged 839.85 0 Cervical Cancer Susceptible Population Classification 05/09/2024 OBSERVATIONAL unchanged 839.85 0 APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia 05/10/2024 INTERVENTIONAL unchanged 838.85 0 Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women 05/10/2024 OBSERVATIONAL unchanged 838.85 0 Sequential Therapies Modeled on Evolutionary Dynamics for Breast Cancer 05/10/2024 INTERVENTIONAL unchanged 838.85 0 Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients 05/10/2024 INTERVENTIONAL unchanged 838.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology